2019;52:e12569
When prescribed and monitored by a qualified healthcare provider, these medications can: Improve insulin sensitivity Reduce appetite and food cravings Support weight loss in certain patients However, outside of a controlled medical environmen t, these effects can become unpredictable and even dangerous
However, clinical trials specifically examining GLP-1 therapy as a rheumatoid arthritis treatment remain limited, and these medications are not approved by the FDA for this indication
Lower estrogen can thin vaginal tissue, reduce lubrication, and alter pH, which weakens defenses against yeast and bacterial infections
The official Australian product information says semaglutide reduces energy intake, increases satiety and fullness, reduces hunger, and lowers the frequency and intensity of cravings
10.1016/j.ceb.2014.09.010 119 RenB